Trial intelligence / Profile preview

Artesunate + amodiaquine for uncomplicated Plasmodium falciparum malaria in Indonesia

ACTRN12611000999932Phase 4Completed

Sponsor
Malaria Sub-directorate, Ministry of Health Indonesia
Start
Dec 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of artesunate and amodiaquine in Malaria, sponsored by Malaria Sub-directorate, Ministry of Health Indonesia. Primary endpoints: Percentage of treatment failures and Percentage of adverse events. Started Dec 2011; status: completed.

02

Drugs

artesunateamodiaquine
03

Conditions

Malaria

Beyond the preview

Go deeper on ACTRN12611000999932.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12611000999932.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call